Search Result "VVC."
Beta Glucan for the Treatment Of Vulvovaginal Candidiasis (VVC) and Recurrent Vulvovaginal Candidiasis (RVVC)
Ebook: Medical Applications of Beta-Glucan
Volume: 1 Year: 2022
Author(s):
Doi: 10.2174/9789815039238122010015
Prophylactic and Therapeutic Role of Vitamin D3 in Combination with Fluconazole Against Vaginal Candidiasis in a Murine Model
Journal: Current Pharmaceutical Biotechnology
Volume: 22 Issue: 13 Year: 2021 Page: 1812-1820
Author(s): Khaled S. Allemailem
Comparison of the Efficacy of Honey and Clotrimazole Cream in the VulvovaginalCandidiasis Treatment: A Systematic Review and Metaanalysis
Journal: Current Drug Therapy
Volume: 18 Issue: 2 Year: 2023 Page: 164-174
Author(s):
Extracellular Phytase in Candida albicans from Different Sources
Journal: Current Enzyme Inhibition
Volume: 12 Issue: 2 Year: 2016 Page: 134-136
Author(s): Ali Z. Mahmoudabadi, Shahrzad Heidarinia, Ali Rezaei-Matehkolaei
Recent Advances in Vaginal Delivery for the Treatment of Vulvovaginal Candidiasis
Journal: Current Molecular Pharmacology
Volume: 14 Issue: 3 Year: 2021 Page: 281-291
Author(s): Sandeep Kaur,Sukhbir Kaur
Exploration of Medicinal Plants as Sources of Novel Anticandidal Drugs
Journal: Current Topics in Medicinal Chemistry
Volume: 19 Issue: 2 Year: 2019 Page: 2579-2592
Author(s): Ajay Kumar,Feroz Khan,Dharmendra Saikia
A Paradigm Shift in the Development of Anti-Candida Drugs
Journal: Current Topics in Medicinal Chemistry
Volume: 19 Issue: 2 Year: 2019 Page: 2610-2628
Author(s): D.V. Gowda,M. Afrasim,S.I. Meenakshi,M. Manohar,S. Hemalatha,H. Siddaramaiah,P. Sathishbabu,S.M. Danish Rizvi,T. Hussain,M.A. Kamal
The Efficacy of Salvia officinalis on the Prevention of Recurrent VulvovaginalCandidiasis: A Randomized, Controlled Clinical Trial
Journal: Current Women`s Health Reviews
Volume: 19 Issue: 4 Year: 2023 Page: 185-196
Author(s): Behnaz Sadeghzadeh Oskouei
Syngonanthus nitens (Bong.) Ruhland Derivatives Loaded into a Lipid Nanoemulsion for Enhanced Antifungal Activity Against Candida parapsilosis
Journal: Current Pharmaceutical Design
Volume: 26 Issue: 14 Year: 2020 Page: 1556-1565
Author(s): Laura C. de Lima,Matheus A.S. Ramos,Luciani G. de Toledo,Camila F. Rodero,Felipe Hilário,Lourdes C. dos Santos,Marlus Chorilli,TaÃs M. Bauab
Oteseconazole: First Approved Orally Bioavailable and SelectiveCYP51 Inhibitor for the Treatment of Patients with RecurrentVulvovaginal Candidiasis
Journal: Current Medicinal Chemistry
Volume: 30 Issue: 37 Year: 2023 Page: 4170-4175
Author(s): Surya K. De